美股市场个股详情
ANIP ANI Pharmaceuticals
- 55.860
- +0.760+1.38%
收盘价 11/21 16:00 (美东)
- 55.860
- 0.0000.00%
盘后 16:12 (美东)
11.74亿总市值-118851市盈率TTM
56.380最高价54.750最低价18.19万股成交量55.600今开55.100昨收1015.66万成交额1.13%换手率65.72市盈率(静)2101.78万总股本70.81052周最高2.89市净率8.97亿流通值48.20052周最低--股息TTM1605.24万流通股392.040历史最高--股息率TTM2.96%振幅4.800历史最低55.831平均价1股每手
关于ANI Pharmaceuticals公司
ANI Pharmaceuticals Inc 开发、制造和销售仿制药。 它生产液体、粉末和口服固体剂量产品。 其产品开发领域包括麻醉剂、溶瘤剂、激素和类固醇，以及涉及缓释和组合产品的复杂配方。 它的一些通用产品包括红霉素琥珀酸乙酯、甲基睾酮酯化雌激素 (EEMT)、依托度酸非诺贝特、氟伏沙明、氢化可的松灌肠剂和万古霉素。 它的地理部门是美国和加拿大，其中大部分收入来自美国。
公司介绍
公司代码ANIP
公司名称ANI Pharmaceuticals
上市日期2003/10/01
成立日期1996
CEOMr. Nikhil Lalwani
所属市场纳斯达克
员工数量642
年结日12-31
公司地址210 Main Street West
城市Baudette
省份明尼苏达州
国家美国
邮编56623
电话1-218-634-3500
董事高管
- 姓名
- 职务
- 年薪
- Nikhil Lalwani
- Director, President and Chief Executive Officer
- 807.84万
- Stephen P. Carey
- Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 257.61万
- Krista Davis
- Senior Vice President and Chief Human Resources Officer
- --
- Christopher Mutz
- Senior Vice President and Head of Rare Diseases
- 191.45万
- Thomas Rowland
- Senior Vice President, Corporate Development & Strategy
- --
- Ori Gutwerg
- Senior Vice President, Generics
- 194.17万
- James G. Marken
- Senior Vice President, Operations and Product Development
- --
- Chad Gassert
- Senior Vice President, Corporate Development and Strategy
- 189.62万
- Meredith W. Cook
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Patrick D. Walsh
- Chairman of the Board
- 42.22万
- Matthew J. Leonard
- Director
- 92.83万
- Muthusamy Shanmugam
- Director, Head of Research and Development and Chief Operating Office, Novitium Operations
- --
- Antonio R. Pera
- Independent Director
- 39.33万
- Dr. Renee P. Tannenbaum, D.Pharm.
- Independent Director
- 39.24万
- Jeanne Thomas
- Independent Director
- 39.58万
- Thomas J. Haughey
- Independent Director
- 41.22万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据